{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:54:27Z","timestamp":1792457667319,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T00:00:00Z","timestamp":1709510400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","thrombosisresearch.com","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.thromres.2024.02.026","type":"journal-article","created":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T07:08:13Z","timestamp":1709363293000},"page":"161-166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Anticoagulation with argatroban using hemoclot\u2122 targets is safe and effective in CARDS patients receiving venovenous extracorporeal membrane oxygenation: An exploratory bi-centric cohort study"],"prefix":"10.1016","volume":"236","author":[{"given":"Timo","family":"Mayerh\u00f6fer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Joannidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Peer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Perschinka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietmar","family":"Fries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Mair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Gasteiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam","family":"Bachler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliane","family":"Kilo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Herkner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schwameis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Schellongowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Nagler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Kornfehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Staudinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Buchtele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2024.02.026_bb0005","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00134-023-07050-7","article-title":"ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies","volume":"49","author":"Grasselli","year":"2023","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.thromres.2024.02.026_bb0010","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1016\/j.jtha.2023.06.034","article-title":"Thombosis, major bleeding, and survival in COVID-19 supported by veno-venous extracorporeal membrane oxygenation in the first vs second wave: a multicenter observational study in the United Kingdom","volume":"21","author":"Arachchillage","year":"2023","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2024.02.026_bb0015","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s00134-022-06794-y","article-title":"Bleeding and thrombotic events in patients with severe COVID-19 supported with extracorporeal membrane oxygenation: a nationwide cohort study","volume":"48","author":"Mansour","year":"2022","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.thromres.2024.02.026_bb0020","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1097\/PCC.0b013e31827127e4","article-title":"Variability in anticoagulation management of patients on extracorporeal membrane oxygenation: an international survey","volume":"14","author":"Bembea","year":"2013","journal-title":"Pediatr. Crit. Care Med."},{"key":"10.1016\/j.thromres.2024.02.026_bb0025","doi-asserted-by":"crossref","first-page":"R275","DOI":"10.1186\/cc10556","article-title":"Bivalirudin-based versus conventional heparin anticoagulation for postcardiotomy extracorporeal membrane oxygenation","volume":"15","author":"Ranucci","year":"2011","journal-title":"Crit. Care"},{"key":"10.1016\/j.thromres.2024.02.026_bb0030","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1097\/MBC.0b013e328317f5aa","article-title":"Argatroban enhances fibrinolysis by differential inhibition of thrombin-mediated activation of thrombin activatable fibrinolysis inhibitor and factor XIII","volume":"19","author":"Nielsen","year":"2008","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.thromres.2024.02.026_bb0035","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.bja.2020.12.010","article-title":"Impaired fibrinolysis in critically ill COVID-19 patients","volume":"126","author":"Bachler","year":"2021","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.thromres.2024.02.026_bb0040","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/s11239-019-01879-w","article-title":"Influence of factor XII deficiency on activated partial thromboplastin time (aPTT) in critically ill patients","volume":"48","author":"Bachler","year":"2019","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.thromres.2024.02.026_bb0045","doi-asserted-by":"crossref","first-page":"e1206","DOI":"10.1097\/CCM.0000000000005179","article-title":"Prevalence and clinical impact of reduced coagulation factor XII activity in patients receiving extracorporeal membrane oxygenation","volume":"49","author":"Buchtele","year":"2021","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.thromres.2024.02.026_bb0050","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/MAT.0000000000002085","article-title":"Prevalence of FXII-deficiency and its relevance to monitoring anticoagulation in adults receiving extracorporeal membrane oxygenation","volume":"70","author":"Brock","year":"2024","journal-title":"ASAIO J"},{"key":"10.1016\/j.thromres.2024.02.026_bb0055","doi-asserted-by":"crossref","DOI":"10.1177\/10760296231207062","article-title":"Prevalence and impact of lupus anticoagulant in patients receiving extracorporeal membrane oxygenation","volume":"29","author":"Kornfehl","year":"2023","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2024.02.026_bb0060","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1164\/rccm.201404-0630CP","article-title":"Position paper for the organization of extracorporeal membrane oxygenation programs for acute respiratory failure in adult patients","volume":"190","author":"Combes","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.thromres.2024.02.026_bb0065","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/MAT.0000000000001432","article-title":"Management of adult patients supported with Venovenous Extracorporeal Membrane Oxygenation (VV ECMO): guideline from the Extracorporeal Life Support Organization (ELSO)","volume":"67","author":"Tonna","year":"2021","journal-title":"ASAIO J."},{"key":"10.1016\/j.thromres.2024.02.026_bb0070","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1056\/NEJMoa1800385","article-title":"Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome","volume":"378","author":"Combes","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2024.02.026_bb0075","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2024.02.026_bb0080","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1016\/j.jtha.2023.08.013","article-title":"Defining heparin resistance: communication from the ISTH SSC Subcommittee of Perioperative and Critical Care Thrombosis and Hemostasis","volume":"21","author":"Levy","year":"2023","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2024.02.026_bb0085","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s13054-021-03581-x","article-title":"Argatroban versus heparin in patients without heparin-induced thrombocytopenia during venovenous extracorporeal membrane oxygenation: a propensity-score matched study","volume":"25","author":"Fisser","year":"2021","journal-title":"Crit. Care"},{"key":"10.1016\/j.thromres.2024.02.026_bb0090","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1177\/0018578719890091","article-title":"Cost-effectiveness of argatroban versus heparin anticoagulation in adult extracorporeal membrane oxygenation patients","volume":"56","author":"Cho","year":"2021","journal-title":"Hosp. Pharm."},{"key":"10.1016\/j.thromres.2024.02.026_bb0095","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13963","article-title":"Membrane oxygenator longevity was higher in argatroban-treated patients undergoing vvECMO","volume":"53","author":"Menninger","year":"2023","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.thromres.2024.02.026_bb0100","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13613-017-0302-5","article-title":"Efficacy and safety of argatroban in patients with acute respiratory distress syndrome and extracorporeal lung support","volume":"7","author":"Menk","year":"2017","journal-title":"Ann. Intensive Care"},{"key":"10.1016\/j.thromres.2024.02.026_bb0105","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1056\/NEJMc2013656","article-title":"Lupus anticoagulant and abnormal coagulation tests in patients with Covid-19","volume":"383","author":"Bowles","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2024.02.026_bb0110","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/cc4975","article-title":"Coagulation abnormalities in critically ill patients","volume":"10","author":"Levi","year":"2006","journal-title":"Crit. Care"},{"key":"10.1016\/j.thromres.2024.02.026_bb0115","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1160\/TH16-06-0468","article-title":"Monitoring anticoagulation with argatroban in critically ill patients: activated partial thromboplastin time versus diluted thrombin time","volume":"116","author":"Keyl","year":"2016","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2024.02.026_bb0120","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.accpm.2020.03.012","article-title":"Diagnosis and management of heparin-induced thrombocytopenia","volume":"39","author":"Gruel","year":"2020","journal-title":"Anaesth. Crit. Care Pain Med."},{"key":"10.1016\/j.thromres.2024.02.026_bb0125","article-title":"Recommendations on the use of anticoagulants for the treatment of patients with heparin-induced thrombocytopenia in Switzerland","volume":"150","author":"Alberio","year":"2020","journal-title":"Swiss Med. Wkly."},{"key":"10.1016\/j.thromres.2024.02.026_bb0130","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1345\/aph.1G319","article-title":"Argatroban dosing of patients with heparin-induced thrombocytopenia and an elevated aPTT due to antiphospholipid antibody syndrome","volume":"40","author":"Pendleton","year":"2006","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.thromres.2024.02.026_bb0135","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/ijlh.12414","article-title":"Limitation of the activated partial thromboplastin time as a monitoring method of the direct thrombin inhibitor argatroban","volume":"37","author":"Guy","year":"2015","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.thromres.2024.02.026_bb0140","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.1016\/j.thromres.2009.12.018","article-title":"Argatroban and renal replacement therapy in a morbidly obese patient with heparin-induced thrombocytopenia: a case report","volume":"126","author":"Godier","year":"2010","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2024.02.026_bb0145","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1186\/s13054-015-1109-0","article-title":"Argatroban in the management of heparin-induced thrombocytopenia: a multicenter clinical trial","volume":"19","author":"Tardy-Poncet","year":"2015","journal-title":"Crit. Care"},{"key":"10.1016\/j.thromres.2024.02.026_bb0150","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00134-021-06593-x","article-title":"Bleeding and thrombotic events in adults supported with venovenous extracorporeal membrane oxygenation: an ELSO registry analysis","volume":"48","author":"Nunez","year":"2022","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.thromres.2024.02.026_bb0155","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/MOP.0000000000001131","article-title":"Bivalirudin in pediatric extracorporeal membrane oxygenation","volume":"34","author":"Ryerson","year":"2022","journal-title":"Curr. Opin. Pediatr."},{"key":"10.1016\/j.thromres.2024.02.026_bb0160","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12959-022-00401-2","article-title":"Evaluation of clinical outcomes in patients treated with heparin or direct thrombin inhibitors during extracorporeal membrane oxygenation: a systematic review and meta-analysis","volume":"20","author":"M\u2019Pembele","year":"2022","journal-title":"Thromb. J."},{"key":"10.1016\/j.thromres.2024.02.026_bb0165","first-page":"1","article-title":"Resistance to unfractionated heparin in the ICU: evaluation and management options","author":"Levy","year":"2023","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.thromres.2024.02.026_bb0170","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s11239-020-02145-0","article-title":"Heparin resistance in COVID-19 patients in the intensive care unit","volume":"50","author":"White","year":"2020","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.thromres.2024.02.026_bb0180","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1056\/NEJMra2104091","article-title":"Heparin resistance - clinical perspectives and management strategies","volume":"385","author":"Levy","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2024.02.026_bb0185","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1111\/jth.15464","article-title":"Heparin - Messias or Verschlimmbesserung?","volume":"19","author":"Swan","year":"2021","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2024.02.026_bb0190","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/MBC.0000000000001133","article-title":"Thromboprophylaxis with argatroban in critically ill patients with sepsis: a review","volume":"33","author":"Bachler","year":"2022","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.thromres.2024.02.026_bb0195","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMcp1411910","article-title":"Clinical practice. Heparin-induced thrombocytopenia","volume":"373","author":"Greinacher","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2024.02.026_bb0200","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1097\/CCM.0000000000004762","article-title":"Timing, outcome, and risk factors of intracranial hemorrhage in acute respiratory distress syndrome patients during venovenous extracorporeal membrane oxygenation","volume":"49","author":"Hunsicker","year":"2021","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.thromres.2024.02.026_bb0205","first-page":"105","article-title":"The direct thrombin inhibitor argatroban: a review of its use in patients with and without HIT","volume":"1","author":"Koster","year":"2007","journal-title":"Biologics"},{"key":"10.1016\/j.thromres.2024.02.026_bb0210","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1177\/039139880602901205","article-title":"Autopsy findings in patients on postcardiotomy extracorporeal membrane oxygenation (ECMO)","volume":"29","author":"Rastan","year":"2006","journal-title":"Int. J. Artif. Organs"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384824000677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384824000677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T14:19:04Z","timestamp":1717251544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384824000677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":41,"alternative-id":["S0049384824000677"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2024.02.026","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anticoagulation with argatroban using hemoclot\u2122 targets is safe and effective in CARDS patients receiving venovenous extracorporeal membrane oxygenation: An exploratory bi-centric cohort study","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2024.02.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}